http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100461756-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02 |
| filingDate | 2002-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100461756-B1 |
| titleOfInvention | A Novel antigenic peptide sequence for the Hepatitis B virus vaccine |
| abstract | The present invention relates to a novel hepatitis B vaccine antigen sequence, and more particularly, to modify a part of the amino acid sequence of preS2 region of Hepatitis B virus (HBV) to remove the binding properties of albumin polymer in human serum to the human body of the existing vaccine. It relates to a novel hepatitis B vaccine antigen sequence which is neutralized by serum albumin components to ameliorate the problem of reduced antigenicity and improves responsiveness to the immune system. |
| priorityDate | 2002-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.